Cargando…
Plasma Metabolomic and Lipidomic Profiling of Metabolic Dysfunction-Associated Fatty Liver Disease in Humans Using an Untargeted Multiplatform Approach
Metabolic dysfunction-associated fatty liver disease (MAFLD) is a complex disorder that is implicated in dysregulations in multiple biological pathways, orchestrated by interactions between genetic predisposition, metabolic syndromes and environmental factors. The limited knowledge of its pathogenes...
Autores principales: | Lin, Xiangping, Liu, Xinyu, Triba, Mohamed N., Bouchemal, Nadia, Liu, Zhicheng, Walker, Douglas I., Palama, Tony, Le Moyec, Laurence, Ziol, Marianne, Helmy, Nada, Vons, Corinne, Xu, Guowang, Prip-Buus, Carina, Savarin, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693407/ https://www.ncbi.nlm.nih.gov/pubmed/36355164 http://dx.doi.org/10.3390/metabo12111081 |
Ejemplares similares
-
Nuclear magnetic resonance-based serum metabolomic analysis reveals different disease evolution profiles between septic shock survivors and non-survivors
por: Liu, Zhicheng, et al.
Publicado: (2019) -
Energetics of endurance exercise in young horses determined by nuclear magnetic resonance metabolomics
por: Luck, Margaux M., et al.
Publicado: (2015) -
Plasma Metabolomics for Discovery of Early Metabolic Markers of Prostate Cancer Based on Ultra-High-Performance Liquid Chromatography-High Resolution Mass Spectrometry
por: Lin, Xiangping, et al.
Publicado: (2021) -
Serum 1H-NMR Metabolomic Fingerprints of Acute-On-Chronic Liver Failure in Intensive Care Unit Patients with Alcoholic Cirrhosis
por: Amathieu, Roland, et al.
Publicado: (2014) -
Nuclear Magnetic Resonance Metabolic Fingerprint of Bevacizumab in Mutant IDH1 Glioma Cells
por: Mesti, Tanja, et al.
Publicado: (2018)